Invention Grant
- Patent Title: Extraction reagent of immunosuppressant drug for immunoassays
-
Application No.: US16838889Application Date: 2020-04-02
-
Publication No.: US11573223B2Publication Date: 2023-02-07
- Inventor: Fengbo Wu , Yongyan Nie , Xiaojuan Shi
- Applicant: SHANGHAI INZEX BIOTECHNOLOGY CO., LTD.
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI INZEX BIOTECHNOLOGY CO., LTD.
- Current Assignee: SHANGHAI INZEX BIOTECHNOLOGY CO., LTD.
- Current Assignee Address: CN Shanghai
- Agency: Dorsey & Whitney LLP
- Priority: CN201510145431.1 20150330
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/94 ; G01N33/50 ; G01N33/543 ; G01N33/487 ; G01N33/577 ; G01N1/44 ; G01N1/40 ; G01N1/28 ; G01N33/533 ; G01N33/537 ; G01N1/38

Abstract:
A reagent for extracting immunosuppressant drugs from a whole blood sample for immunoassay includes protein denaturant, proteolytic enzyme, surfactant and pH buffer. A method and an immunoassay kit for detection of the immunosuppressant concentration in a whole blood sample uses the extraction reagent. The extraction reagent doesn't need the use of organic solvent as that in the traditional extraction methods, therefore the adverse effects of the organic solvent on the antibody activity in a detection system and the other relative defects associated to its use are obviated. The drug extraction process doesn't need centrifugation, as the processed sample can be directly applied for immunoassay. The operation for drug extraction is simple, and the detection result based on this extraction method is accurate.
Public/Granted literature
- US20200232975A1 EXTRACTION REAGENT OF IMMUNOSUPPRESSANT DRUG FOR IMMUNOASSAYS Public/Granted day:2020-07-23
Information query
IPC分类: